• Contact
  • +31 (0)30 800 4800
  • nl | en
  • Home
  • About BBio
    • Our story
    • How it started
    • Science park
    • Together with
  • What we produce
    • Product overview
    • How we do it
    • Report side effects
  • Look inside
    • Projects
    • News
  • Contact
+31 (0)30 800 4800
nl | en



From cell to vaccine.
Quality first.

 

From cell to Vaccine.
This is how we do it.

Developing a vaccine takes a lot of effort. To be able to supply the world’s population with reliable vaccines, our product undergoes quite a journey. We will gladly show you how we do this!

How we do it.

BCG
Bilthoven Biologicals produces BCG for the treatment of bladder cancer on behalf of third parties. 
Combination DT-IPV vaccine
The DT-IPV combination vaccine (diphteria, tetanus and poliomyelitis) can be used as the first (primary) inoculation, or as a booster vaccination.
Poliomyelitis vaccine (IPV)
This vaccine is also used in the worldwide polio eradication program.
Tetanus vaccine
The Tetanus vaccine protects against infections with the Tetanus bacterium.

facts & figures
Number of doses IPV BBio 2014-2023

283,953,887 doses IPV
were delivered between 2014 en 2023
129 countries
over the world use IPV from BBio
On 6 different continents
BBio contributes to the eradication of polio
On 25th of August 2020 WHO declared Africa polio free
the certification came four years after the last case of polio in Africa was detected.
1992-1993 polio last occurred
in the Netherlands

The story of our vaccines

News

In Memoriam: Ad van den Biggelaar

It is with deep sadness that we share the news of the passing of Ad van den Biggelaar, COO at Bithoven Biologicals (BBio). Ad was a beloved colleague, whose legacy and influence within our company are undeniable.
News

European Commission Grants Marketing Authorisation for SIILTIBCY® – A Novel Tuberculosis Skin Test in Europe

SIILTIBCY® is a tuberculosis skin test approved in European Union that detects tuberculosis infection regardless of BCG vaccination status with demonstrated sensitivity and specificity.
News

Bilthoven Biologicals opens Pandemic Preparedness Vaccine Facilities

The new state-of-the-art facilities have received approval from European Commission EU FAB and ensures vaccine accessibility for Europe in the event of a pandemic situation.
Meer verhalen
  • About BBio
  • Look inside
  • Contact
Our vaccines
  • BCG
  • Tetanus vaccine
  • Combination DT-IPV vaccine
  • Poliomyelitis vaccine (IPV)
  • Report side effects
Latest vacancies
  • QA Systems & Compliance Manager
  • Operator I & II - Mediabereiding & Afvullen
  • QC Technician
  • Supervisor Cleaning & Sterilization
Contact
Visiting address
Antonie van Leeuwenhoeklaan 9
3721 MA Bilthoven

+31 (0)30 800 4800
info@bbio.nl
Travel directions
© 2025 Bilthoven Biologicals | General terms and conditions | Privacy Statement
Manage cookie consent

To provide you with the best experience on our website, we use technologies such as cookies to store and/or access information about your device and your website usage. If you do not consent or withdraw your consent, certain functions and features on our website will not work for you.


Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service expressly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that have not been requested by the subscriber or user.
Statistics

The technical storage or access used solely for statistical purposes. The technical storage or access used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance by your Internet Service Provider, or additional information from a third party, information stored or retrieved solely for this purpose generally cannot be used to identify you.
Marketing
The technical storage or access is necessary to create user profiles for sending advertising, or to track the user on a website or across different websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}